Contrast-Enhanced Spectral Mammography-Based Radiomics Nomogram for the Prediction of Neoadjuvant Chemotherapy-Insensitive Breast Cancers

Contrast-Enhanced Spectral Mammography-Based Radiomics Nomogram for the Prediction of Neoadjuvant Chemotherapy-Insensitive Breast Cancers

PurposeWe developed and validated a contrast-enhanced spectral mammography (CESM)-based radiomics nomogram to predict neoadjuvant chemotherapy (NAC)-insensitive breast cancers prior to treatment.MethodsWe enrolled 117 patients with breast cancer who underwent CESM examination and NAC treatment from...

Full description

Bibliographic Details
Main Authors: Zhongyi Wang, Fan Lin, Heng Ma, Yinghong Shi, Jianjun Dong, Ping Yang, Kun Zhang, Na Guo, Ran Zhang, Jingjing Cui, Shaofeng Duan, Ning Mao, Haizhu Xie
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Oncology
Subjects:
radiomics
breast cancer
contrast-enhanced spectral mammograph
neoadjuvant chemotherapy
oncology
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.605230/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.605230/full

Similar Items